This inventor holds 1 USPTO granted patent. Top assignee: Solco Basel Ag. Active years: 1983.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1983
Title: Siegfried Woltmann: Innovator in Colloidal Solutions
Introduction
Siegfried Woltmann is a notable inventor based in Magden, Switzerland. He has made significant contributions to the field of biomedical engineering, particularly in the preparation of physiologically degradable colloidal solutions. His innovative work has implications for medical imaging and diagnostics.
Latest Patents
Woltmann holds a patent for a process that involves the preparation of a colloidal solution of human serum albumin. This process includes mixing an aqueous solution of human serum albumin with a non-ionic surface-active agent and an acid solution of a tin(II) salt. The pH is adjusted to a range of 3.5 to 8.0, followed by heating at a constant temperature between 45°C and 100°C until complete hydrolysis of the tin(II) salt and denaturation of the albumin occur. The resulting colloidal solution can also be lyophilized. By treating the solution or the lyophilizate with a 99mTc-pertechnetate solution, a colloidal preparation is obtained for scintigraphy of the reticuloendothelial system or the lymphatic system. This process allows for selective colloid production with varying particle sizes.
Career Highlights
Woltmann is associated with Solco Basel AG, where he continues to develop innovative solutions in his field. His work has garnered attention for its potential applications in medical diagnostics and treatment.
Collaborations
Woltmann collaborates with Han-Lie Chia, contributing to advancements in their shared field of expertise.
Conclusion
Siegfried Woltmann's contributions to the preparation of colloidal solutions represent a significant advancement in biomedical engineering. His innovative processes have the potential to enhance medical imaging techniques and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile